Loading data for GELS — first visit, this takes a few seconds.
Gelteq Limited (GELS)
NasdaqCM: GELS
· Echtzeitkurs · USD
0.56
+0.03 (5.66%)
Zum Schluss: Aug 19, 2026, 3:28 PM
Gelteq Limited (GELS) Stock Price, Analysis & Data
5.66% (1D)
Keine Daten verfügbar
| Geld | n/a |
| Marktkapitalisierung | 6.03 Mio |
| Umsatz (TTM) | 471.8K |
| Nettogewinn (TTM) | -7.08 Mio |
| Beta | n/a |
| EPS (ttm) | -0.52 |
| KGV (TTM) | n/a |
| Forward-KGV | n/a |
| KBV (TTM) | 0.63 |
| KUV (TTM) | 12.77 |
| Earnings Date | n/a |
| Brief | n/a |
| Volumen | 5,327 |
| Ø Vol. (20D) | 3,682,619 |
| Eröffnung | 0.53 |
| Vortagesschluss | 0.53 |
| Tagesspanne | 0.53 - 0.59 |
| 52-Wk Range | 0.39 - 2.02 |
| Analyst | n/a |
| Kursziel | n/a |
| Dividenden | n/a |
| Ex-Dividenden-Datum | n/a |
Über GELS
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia....
Sektor Healthcare
IPO Datum Oct 29, 2024
Mitarbeiter 7
Börse NasdaqCM
Tickersymbol GELS
Website https://www.gelteq.com
Finanzielle Entwicklung
Im Jahr 2025 betrug der Umsatz von Gelteq 165.65K, ein Anstieg von undefined% im Vergleich zum Vorjahr (0). Der Gewinn lag bei -6.65 Mio, ein Anstieg von 87.4 %.
Finanzberichte
vor 11 Monaten · MT Newswires
Top Midday GainersSINTX Technologies (SINT) said Wednesday it published a peer-reviewed study demonstrating that silic